|
|
|
| Relationship of Serum IL-38, sTREM-1, and IL-6 Levels with Status of Chronic Obstructive Pulmonary Disease |
| LU Sha-sha, DUAN Yong-bo, SONG Yu, et al |
| Shangluo Center for Disease Control and Prevention, Shangluo 726000 |
|
|
|
|
Abstract 【Objective】To investigate the changes of serum interleukin-38 (IL-38), interleukin-6 (IL-6) and soluble myeloid receptor-1 (sTREM-1) in patients with chronic obstructive pulmonary disease (COPD) and their significance. 【Methods】A total of 100 patients with COPD were selected as the COPD group while 100 healthy volunteers without lung disease were selected as the control group. Serum IL-38, sTREM-1, and IL-6 levels were measured in both groups. According to COPD condition, patients were divided into a stable phase group and an acute stratification group. 【Results】The levels of serum IL-38, sTREM-1, and IL-6 in the COPD group were significantly higher than those in the control group (P<0.05). Serum IL-38, sTREM-1, IL-6 levels of patients in the acute stratification group were significantly higher than those of patients in the stable phase group (P<0.05). FEV1%pred (the forced expiratory volume in the first second as a percentage of the predicted value) and FEV1/FVC (forced vital capacity) in patients with acute exacerbation of COPD were lower than that in stable phase, with statistically significant difference (P<0.05). The CAT score of the acute stratification group was higher than that of the stable phase group (P<0.05). The CAT score of COPD patients was positively correlated with IL-38, sTREM-1 and IL-6 levels (P<0.05). 【Conclusion】The levels of serum IL-38, sTREM-1, and IL-6 in patients with COPD increased significantly and were related to the severity of the disease.
|
|
Received: 28 August 2020
|
|
|
|
|
|
[1] 关晶, 李建民.无创正压机械通气治疗慢性阻塞性肺疾病急性加重期呼吸衰竭患者疗效观察[J].湖南师范大学学报(医学版), 2018, 15(3):41-43.
[2] 朱亚茜,马淑萍,董维刚,等.血清白细胞介素38与慢性阻塞性肺疾病急性加重合并肺栓塞的相关性[J].中华医学杂志,2019,99(12):929-933.
[3] 董肖琦,沈茜,姚一楠,等.慢性阻塞性肺疾病急性加重患者呼出气冷凝液中白细胞介素-6与白三烯B4的检测及其临床意义[J].中华结核和呼吸杂志,2017,40(2):114-117.
[4] 韩美玲,陈绍平.可溶性髓样细胞触发受体-1在慢性阻塞性肺疾病中作用的研究进展[J].中国临床新医学,2016,9(11):1042-1045.
[5] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,33(4):255-264.
[7] MONSTERRAT-CAPDEVILA J, GODOY P, et al.Risk of exacerbation in chronic obstructive pulmonary disease:a primary care retrospective cohort study[J].BMC Fam Pract,2015,16(3):173.
[8] 聂晓红,张意,何瀚夫,等.慢性阻塞性肺疾病患者血浆前白蛋白、同型半胱氨酸水平及与超敏C反应蛋白、体重指数的相关性[J].中国呼吸与危重监护杂志,2018,17(4):331-335.
[9] 霍晋,王蕾,贾原,等.老年慢性阻塞性肺疾病合并骨质疏松血清白细胞介素-6及C反应蛋白相关研究[J].中国药物与临床,2018,18(12):2104-2106.
[10] 叶青,朱建勇,张立波,等.血清白细胞介素-6、触珠蛋白及淀粉样蛋白A对慢性阻塞性肺疾病患者肺部感染的鉴别诊断研究[J].中华医院感染学杂志,2017,27(13):2961-2964.
[11] 朱亚茜,马淑萍,李波,等.白细胞介素38在慢性阻塞性肺疾病患者血清中的表达及临床意义[J].中华医学杂志,2018,98(10):759-762. |
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2021, 38(6): 938-940. |
|
|
|
|
2021, Vol. 38 
